Stewardship Flashcards

1
Q

What can we do to improve/reduce antimicrobial use in animals?

A
  • Use antimicrobials less often
  • Use lower priority drugs when possible
  • Dose them properly
  • Optimize durations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is longer course of antibiotics always better?

A

no, pretty much all studies have found that short course is equally effective
> watch out for dogma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common conception: IV antibiotics are required for many serious infections.
-Truth?

A
  • Antimicrobial efficacy is dependent on the drug concentration at the site of infection
  • If a drug is bioavailable orally, has established oral dosing regimens and is administered successfully, and there are no patient factors that would inhibit drug absorption, does route matter??
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

where did idea that IV is better for serious infections come from?

A
  • Humans, osteomyelitis
  • Waldvogel et al (1970) reported IV penicillin or aminoglycosides, with no oral
    treatment
  • Concluded “…osteomyelitis is rarely controlled without the combination of
    careful, complete surgical debridement and prolonged (4 to 6 weeks)
    parenteral antibiotic therapy at high dosage”
  • Paper has traditionally been cited as indicating IV treatment is needed
  • Endocarditis
  • Multiple studies in the 1940s/1950s showed oral sulfanilamide, erythromycin
    or tetracycline were inferior to IV penicillin
  • Finland et al 1954 review article: “Presumably, the oral route is at times
    successful…it is more likely, however, that such usage is responsible for many therapeutic failures….However, little of this type of experience is recorded, and therefore this assumption cannot be authenticated”
  • But, were differences because of ROUTE or DRUG?
  • Sulfa,oralerythromycinandtetracyclinearepooroptionsfortypicalhuman
    endocarditis because of low peak blood drug levels cases while penicillin is (was) an excellent option
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • “If you start and antimicrobial, you have to use it for X days to avoid development of resistance”
  • truth?
A
  • Each dose of an antimicrobial will inhibit susceptible organisms and select for resistant organisms.
  • More doses = more selection pressure.
  • I’m not aware of any data, in any species, that show longer courses of antibiotics result in less resistance, or that clinical relapses lead to resistance
  • I can’t think of any pathophysiology for increased resistance risk with less treatment
  • Inadequate treatment duration could impact treatment efficacy, not likelihood of resistance emergence.
  • When it’s determined there’s no clinical need for an antimicrobial, it should be stopped
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

“I took over a case this morning and it’s on ampicillin, clindamycin, enrofloxacin, doxycycline and metronidazole. Do we need all those drugs?”
- what do we do?

A

De-escalation
* Reconsideration of empirical therapy
> After case has progressed
> When lab results are available
* Regular review of the antimicrobial regimen
* Consideration of transition of inpatients to outpatient-amenable treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

“Bactericidal antibiotics should be used for serious infections, immunocompromised patients, or immune priveleged sites”
-truth?

A
  • Classic assumption:
  • Bactericidal drugs kill while bacteriostatic drugs inhibit growth
  • Bactericidal definition:
  • Drugs where the in vitro minimum bactericidal concentration (MBC) is <= 4X
    the MIC and a 99.9% reduction of bacterial concentration is achieved after growth in vitro for 18-24h
  • But…bacteriostatic and bactericidal are
  • In vitro properties
  • Somewhat arbitrarily defined
  • Impacted by bacterial inoculum, growth conditions, growth phase, local site
    physiologic properties…
  • Not black-and-white:
  • Some ‘bacteriostatic’ drugs are bactericidal for certain bacteria or in some situations * Some ‘bactericidal’ drugs do not hit that MBC:MIC ratio at the site of infection
  • A drug could kill 99.99% of bacteria in vitro at a different inoculum concentration or time than the arbitrary and be classified as bacteriostatic
  • A bactericidal drug could kill <99.9% of bacteria with higher inocula or different conditions
  • Review of 56 trials since 1985
  • 49 reported no difference between cidal and static drugs * 6 reported superiority of bacteriostatic drugs
  • 1 reported superiority of bactericidal drugs
    > But…static drug was underdosed based on retrospective PK/PDanalysis
  • “It is time to abandon the notion that bactericidal antibiotic agents are
    intrinsically more effective than bacteriostatic agents” * Pick the best drug…ignore cidal vs static
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

human data for static vs cidal drugs?

A
  • No demonstrated significant clinical benefit of bactericidal drugs for:
  • Immunocompromised hosts
  • Immune privileged sites
  • Severe disease (e.g. sepsis)
  • Some bacteriostatic drugs are recommended first line treatment for serious infections (e.g. linezolid for bacterial endocarditis, McDonald 2023)
  • Good study for endocarditis and meningitis is lacking
  • Pick the best drug…ignore cidal vs static
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bacteriostatic effects (decreasing growth) inhibit bactericidal effects (that typically occur during growth)
-is this true? should we not combine cidal and static drugs?

A
  • not necessarily, but can be an ok rule of thumb…
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Culture and Susceptibility Testing pros and cons

A

Pros
* Targeted antimicrobial treatment
* Confirmation of disease
* Better interpretation if treatment fails

Cons
* $$
* Time delay
* Misleading results with improper sampling, lab methods, contamination…

> A properly collected sample is rarely contraindicated, but it’s not always indicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • 3 yr old indoor/outdoor cat
  • Presented for facial swelling of at least a few days’ duration
  • Quiet, poor appetite
  • Fever
  • Pain over neck
  • What is the disease process? * Where is the infection?
  • What do you do?
A
  • Incision and drainage
  • Antibiotics for tissue infection *
    Likely pathogens
  • Pasteurella, Staph, Strep, Enterobacterales
  • Easy to penetrate tissue sites (outside the abscess)
  • Cat moderately amenable to treatment
  • Amoxicillin/clavulanic acid: 3-5d
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Would you culture…..
* 5yr old dog with first episode of cystitis?

A

probably not, asl client

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Would you culture…..
* 5 yr old dog with first episode of cystitis but a history of recurrent
superficial folliculitis?

A

more useful to have a culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Would you culture…..
* 5 yr old dog with first episode of cystitis whose owner is frequently
hospitalized?

A

push to culture this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Would you culture…..
* 3 yr old cat with first episode of cystitis?

A

yes - very low probability it is bacterial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Would you culture…..
* 2 yr old standardbred horse with suspected pleuropneumonia?

A

yes - very sick. start broader spectrum and de-escalate

17
Q

Would you culture…..
* 2 day old TB foal that is weak and not nursing?

A

yes, high consequence

18
Q

Would you culture…..
* Feedlot steer that died of pneumonia?

A

maybe - will culture help with herd level decisions?

19
Q

When to culture?

A
  • Need the result for a diagnosis of
    > Presence/absence of bacterial disease
    > The likely bacterial cause
  • Need the result to guide therapy
  • The greater the likelihood that my empirical therapy will fail, and the
    greater the implications of treatment failure, the greater the need for a culture
20
Q

eg. UTI vs bacteriuria (or similar)
> how is the patient? do we need to treat?
> issues that may occur from treating bacteriuria - what must we ask?

A
  • Did treatment prevent earlier severe infections?
    Or
  • Did treatment select for a bacterium that ultimately resulted in life- threatening infection?

In all cases:
* Treat the patient, not the lab report.
* Not all bugs need to be killed.

21
Q

When peri-operative antimicrobials are indicated, therapeutic levels should be:

A

present at the surgical site during the period of risk.

22
Q

should we give antibiotics after a surgrey for some time?

A

no, not useful - only useful just before and during the act.
> when used after the fact, nothing good occurs

23
Q

antibiotics that are very important for humans - caution

A
  • Fluoroquinolones
  • 3rd gen cephalosporins
24
Q

antibiotics that are important for humans but not theeee most (still use caution)

A
  • aminoglycosides
  • macrolides
25
Q

antibiotics that are more commonly used in animals, less risk for humans hopefully

A
  • Penicillins
  • Potentiated penicillins
  • 1st and 2nd gen cephalosporins
  • Lincosamdes
  • Tetracyclines
  • Nitroimidazoles
  • Sulfonamides/potentiated sulfas
26
Q

What do you consider when choosing an antibiotic?

A
  • pathogen
  • infection site
  • disease process
    ()
  • patient
    ()
  • safety
  • frequency
  • cost
  • route / ability to treat
    ()
  • importance to human med
  • withdrawl period
  • labelling

always think:
Do we need an antibiotic?
Do we need anything else?